CLINICAL_TRIALS
trial_result
· 2021-01-22
Clinical Trial Update: KRN125 for Mobilization of Hematopoietic Stem Cells [Phase 2]
Summary
Phase 2 trial update for KRN125 in mobilization of hematopoietic stem cells has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Peripheral Blood Stem Cell Transplantation | Phase 2 | Status: COMPLETED